As of 2025-12-24, the Relative Valuation of Pulse Biosciences Inc (PLSE) is (41.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.58 USD, the upside of Pulse Biosciences Inc based on Relative Valuation is -386.7%.
The range of the Relative Valuation is (38.90) - (40.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.3x - 46.3x | 41.4x |
| Forward P/E multiples | 31.3x - 36.8x | 34.4x |
| Fair Price | (38.90) - (40.60) | (41.79) |
| Upside | -366.8% - -378.5% | -386.7% |
| Date | P/E |
| 2025-12-22 | -13.78 |
| 2025-12-19 | -13.84 |
| 2025-12-18 | -13.04 |
| 2025-12-17 | -12.93 |
| 2025-12-16 | -12.90 |
| 2025-12-15 | -12.81 |
| 2025-12-12 | -12.91 |
| 2025-12-11 | -12.47 |
| 2025-12-10 | -12.88 |
| 2025-12-09 | -12.41 |
| 2025-12-08 | -12.23 |
| 2025-12-05 | -12.03 |
| 2025-12-04 | -12.03 |
| 2025-12-03 | -12.23 |
| 2025-12-02 | -11.78 |
| 2025-12-01 | -12.02 |
| 2025-11-28 | -12.41 |
| 2025-11-26 | -12.51 |
| 2025-11-25 | -12.09 |
| 2025-11-24 | -11.87 |
| 2025-11-21 | -11.80 |
| 2025-11-20 | -11.48 |
| 2025-11-19 | -11.80 |
| 2025-11-18 | -12.31 |
| 2025-11-17 | -12.47 |
| 2025-11-14 | -13.06 |
| 2025-11-13 | -12.82 |
| 2025-11-12 | -13.60 |
| 2025-11-11 | -13.89 |
| 2025-11-10 | -13.92 |
| 2025-11-07 | -14.02 |
| 2025-11-06 | -14.26 |
| 2025-11-05 | -14.75 |
| 2025-11-04 | -14.56 |
| 2025-11-03 | -15.23 |
| 2025-10-31 | -15.35 |
| 2025-10-30 | -15.32 |
| 2025-10-29 | -15.52 |
| 2025-10-28 | -15.73 |
| 2025-10-27 | -15.87 |
| 2025-10-24 | -16.39 |
| 2025-10-23 | -15.77 |
| 2025-10-22 | -15.64 |
| 2025-10-21 | -16.40 |
| 2025-10-20 | -16.51 |
| 2025-10-17 | -15.92 |
| 2025-10-16 | -15.93 |
| 2025-10-15 | -15.68 |
| 2025-10-14 | -15.65 |
| 2025-10-13 | -15.72 |